Alterations of Gut Microbiome, Function, and Its Intervention After Defunctioning Ileostomy
- Conditions
- Ileostomy - StomaRectal CancerMicrobial DiseaseIntestinal Functional Disorder
- Interventions
- Drug: MIYAIRI 588
- Registration Number
- NCT05759741
- Lead Sponsor
- Huashan Hospital
- Brief Summary
This study focused on the alterations of gut microbiome and function during defunctioning ileostomy, and observed the effects of probiotic intervention on intestinal microbiome and function. The investigators looked forward to find the specific intestinal maladjusted flora from this work, which could provide a new scheme for the subsequent treatment of the damaged intestinal function and the reduction of the incidence of postoperative complication.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 64
- Patients with primary rectal cancer received total mesolectal resection combined with defunctioning ileostomy.
- Patients voluntarily sign informed consent.
- Disease progression or death after surgery.
- Patients with inflammatory bowl disease.
- Patients need to be on antibiotics/other probiotics for a long time.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description MIYAIRI 588 group MIYAIRI 588 4 tablets of MIYAIRI 588 were inserted into distal ileostomy once a week for 6 months.
- Primary Outcome Measures
Name Time Method Wexner incontinence score 1 year Assess defecation function,the score range is 0-20, 0 is normal, 20 is complete incontinence
- Secondary Outcome Measures
Name Time Method fecal incontinence quality-of-life scale 1 year The Fecal Incontinence Quality of Life Scale is composed of a total of 29 items; these items form four scales: Lifestyle (10 items), Coping/Behavior (9 items), Depression/Self-Perception (7 items), and Embarrassment (3 items). The score of each scale is 1-4 points. The higher the score, the worse the quality of life.
Rate of postoperative complications 1 month after operation Such as anastomotic leakage, operative death, intestinal obstruction, intestinal infection,etc.
Trial Locations
- Locations (1)
Huashan hospital
🇨🇳Shanghai, China